1,058
Participants
Start Date
February 29, 2008
Primary Completion Date
May 31, 2009
linagliptin
active
placebo
placebo to linagliptin 5 mg
1218.18.54001 Boehringer Ingelheim Investigational Site, Capital Federal
1218.18.54002 Boehringer Ingelheim Investigational Site, Capital Federal
1218.18.54004 Boehringer Ingelheim Investigational Site, Capital Federal
1218.18.54005 Boehringer Ingelheim Investigational Site, Capital Federal
1218.18.54010 Boehringer Ingelheim Investigational Site, Capital Federal
1218.18.54014 Boehringer Ingelheim Investigational Site, Corrientes
1218.18.54009 Boehringer Ingelheim Investigational Site, Córdoba
1218.18.54013 Boehringer Ingelheim Investigational Site, Córdoba
1218.18.54003 Boehringer Ingelheim Investigational Site, Mar del Plata
1218.18.54012 Boehringer Ingelheim Investigational Site, Mar del Plata
1218.18.54011 Boehringer Ingelheim Investigational Site, Mendoza
1218.18.54015 Boehringer Ingelheim Investigational Site, Parque Velez Sarfield
1218.18.54006 Boehringer Ingelheim Investigational Site, Rosario
1218.18.54007 Boehringer Ingelheim Investigational Site, Salta
1218.18.32005 Boehringer Ingelheim Investigational Site, Bruges
1218.18.32007 Boehringer Ingelheim Investigational Site, Brussels
1218.18.32006 Boehringer Ingelheim Investigational Site, Edegem
1218.18.32004 Boehringer Ingelheim Investigational Site, Genk
1218.18.32003 Boehringer Ingelheim Investigational Site, Ghent
1218.18.32002 Boehringer Ingelheim Investigational Site, Huy
1218.18.32001 Boehringer Ingelheim Investigational Site, Liège
1218.18.01005 Boehringer Ingelheim Investigational Site, Calgary
1218.18.01010 Boehringer Ingelheim Investigational Site, Calgary
1218.18.01003 Boehringer Ingelheim Investigational Site, Vancouver
1218.18.01011 Boehringer Ingelheim Investigational Site, Vancouver
1218.18.01006 Boehringer Ingelheim Investigational Site, Etobicoke
1218.18.01009 Boehringer Ingelheim Investigational Site, Hamilton
1218.18.01002 Boehringer Ingelheim Investigational Site, London
1218.18.01012 Boehringer Ingelheim Investigational Site, Oakville
1218.18.01008 Boehringer Ingelheim Investigational Site, Sarnia
1218.18.01001 Boehringer Ingelheim Investigational Site, Toronto
1218.18.01004 Boehringer Ingelheim Investigational Site, Montague
1218.18.01007 Boehringer Ingelheim Investigational Site, Saskatoon
1218.18.86001 Boehringer Ingelheim Investigational Site, Beijing
1218.18.86002 Boehringer Ingelheim Investigational Site, Beijing
1218.18.86004 Boehringer Ingelheim Investigational Site, Beijing
1218.18.86013 Boehringer Ingelheim Investigational Site, Chengdu, Sichuan Province
1218.18.86009 Boehringer Ingelheim Investigational Site, Dalian
1218.18.86011 Boehringer Ingelheim Investigational Site, Guangzhou
1218.18.86014 Boehringer Ingelheim Investigational Site, Haerbin
1218.18.86005 Boehringer Ingelheim Investigational Site, Nanjing, Jiangsu Province
1218.18.86008 Boehringer Ingelheim Investigational Site, Qingdao
1218.18.86015 Boehringer Ingelheim Investigational Site, Shanghai
1218.18.86010 Boehringer Ingelheim Investigational Site, Shenyang
1218.18.86003 Boehringer Ingelheim Investigational Site, Weizikeng
1218.18.86007 Boehringer Ingelheim Investigational Site, Wuhan
1218.18.86012 Boehringer Ingelheim Investigational Site, Wuhan, Hubei Province
1218.18.86006 Boehringer Ingelheim Investigational Site, Xian, Shanxi Province
1218.18.49004 Boehringer Ingelheim Investigational Site, Aschaffenburg
1218.18.49028 Boehringer Ingelheim Investigational Site, Bad Mergentheim
1218.18.49022 Boehringer Ingelheim Investigational Site, Berlin
1218.18.49024 Boehringer Ingelheim Investigational Site, Bosenheim
1218.18.49020 Boehringer Ingelheim Investigational Site, Dresden
1218.18.49101 Boehringer Ingelheim Investigational Site, Mainz
1218.18.49003 Boehringer Ingelheim Investigational Site, Neuwied
1218.18.49007 Boehringer Ingelheim Investigational Site, Nuremberg
1218.18.49014 Boehringer Ingelheim Investigational Site, Saarbrücken
1218.18.63005 Boehringer Ingelheim Investigational Site, Manila
1218.18.63002 Boehringer Ingelheim Investigational Site, Marikina City
1218.18.63001 Boehringer Ingelheim Investigational Site, Pasig
1218.18.63004 Boehringer Ingelheim Investigational Site, Quezon City
1218.18.63003 Boehringer Ingelheim Investigational Site, San Juan City
1218.18.70014 Boehringer Ingelheim Investigational Site, Arkhangelsk
1218.18.70012 Boehringer Ingelheim Investigational Site, Moscow
1218.18.70013 Boehringer Ingelheim Investigational Site, Rostov-on-Don
1218.18.70015 Boehringer Ingelheim Investigational Site, Saint Petersburg
1218.18.70016 Boehringer Ingelheim Investigational Site, Samara
1218.18.82004 Boehringer Ingelheim Investigational Site, Busan
1218.18.82011 Boehringer Ingelheim Investigational Site, Daegu
1218.18.82008 Boehringer Ingelheim Investigational Site, Incheon
1218.18.82010 Boehringer Ingelheim Investigational Site, Jeonju
1218.18.82002 Boehringer Ingelheim Investigational Site, Pusan
1218.18.82001 Boehringer Ingelheim Investigational Site, Seoul
1218.18.82005 Boehringer Ingelheim Investigational Site, Seoul
1218.18.82006 Boehringer Ingelheim Investigational Site, Seoul
1218.18.82007 Boehringer Ingelheim Investigational Site, Seoul
1218.18.82009 Boehringer Ingelheim Investigational Site, Seoul
1218.18.82003 Boehringer Ingelheim Investigational Site, Suwon
1218.18.88605 Boehringer Ingelheim Investigational Site, Changhua
1218.18.88604 Boehringer Ingelheim Investigational Site, Taichung
1218.18.88606 Boehringer Ingelheim Investigational Site, Tainan City
1218.18.88601 Boehringer Ingelheim Investigational Site, Taipei
1218.18.88602 Boehringer Ingelheim Investigational Site, Taipei
1218.18.88603 Boehringer Ingelheim Investigational Site, Taipei
1218.18.88607 Boehringer Ingelheim Investigational Site, Taipei
1218.18.88608 Boehringer Ingelheim Investigational Site, Taoyuan District
1218.18.90003 Boehringer Ingelheim Investigational Site, Erzurum
1218.18.90005 Boehringer Ingelheim Investigational Site, Istanbul
1218.18.90001 Boehringer Ingelheim Investigational Site, Izmir
1218.18.90004 Boehringer Ingelheim Investigational Site, Konya
1218.18.44005 Boehringer Ingelheim Investigational Site, Ashford
1218.18.44004 Boehringer Ingelheim Investigational Site, Baillieston, Glasgow
1218.18.44001 Boehringer Ingelheim Investigational Site, Bath
1218.18.44003 Boehringer Ingelheim Investigational Site, Burbage
1218.18.44010 Boehringer Ingelheim Investigational Site, Bury Saint Edmonds
1218.18.44009 Boehringer Ingelheim Investigational Site, Cardiff
1218.18.44008 Boehringer Ingelheim Investigational Site, Glasgow
1218.18.44002 Boehringer Ingelheim Investigational Site, Penarth
1218.18.44006 Boehringer Ingelheim Investigational Site, Reading
1218.18.44007 Boehringer Ingelheim Investigational Site, Waterloo, Liverpool
Lead Sponsor
Boehringer Ingelheim
INDUSTRY